Tag: Hemophilia B
-
Hemophilia A Gene Therapy
New drug for Hemophilia A Gene Therapy approved by USFDA. US FDA approved Hemophilia A Gene Therapy. Hemophilia is a disease which causes uncontrolled excessive bleeding, due to absence of clotting factors which help in formation of solid clot that prevents excessive bleeding and wound healing. Patients affected with Hemophilia suffer bleeding bruises, bleeding in…
-
USFDA approves first Gene Therapy Drug for Hemophilia B
What is Hemophilia B ? Patients affected with Hemophilia B suffer uncontrolled bleeding from any part of body from inside or from any damaged or wounded body part, some times without any bruise or any cut bleeding occurs from internal organs or oral cavity. Symptoms of Hemophilia B Patients affected with Hemophilia B suffer bleeding…
Guidelines on Pharmaceutical Manufacturing Pharma Quality Assurance Quality Management System 